Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory approvals
CRO
UK regulator looks to halve approval times for low-risk trials
The Medicines and Healthcare products Regulatory Agency's new guidelines will cut by half the time it takes to approve lower-risk clinical trials.
Joseph Keenan
Oct 12, 2023 7:05am
BeVinced debuts as CRO focused on medical device services
Mar 29, 2023 8:31am
Moderna posts come-from-behind RSV data
Jan 17, 2023 4:55pm
Agenus withdraws cervical cancer application for balstilimab
Oct 22, 2021 8:00am
FDA stands by Aduhelm approval, use of accelerated pathway
Jul 13, 2021 3:33pm
Boston Scientific’s radioactive implant extends cancer survival
Mar 29, 2021 11:58am
